Navigation Links
Chiltern Welcomes Cedric Burg And James Gunter
Date:12/10/2012

LONDON and WILMINGTON, N.C., Dec. 10, 2012 /PRNewswire/ -- Chiltern International Limited (Chiltern), a global contract research organization (CRO), announced that Dr. Cedric Burg and James Gunter have joined Chiltern, bringing their expertise in clinical research to serve our clients' needs and to strengthen our Global Clinical Development services.

"It gives me great pleasure to announce that Dr. Cedric Burg has been appointed to the position of Vice President, Global Clinical Development, Americas," stated Aize Smink, Chief Operating Officer, Chiltern. "Cedric will head Chiltern's Global Clinical Development business in the Americas, where he will lead our teams in Latin and North America to continue the expansion of our services and capabilities. We believe that Cedric's international experience and exposure to both pharma and CROs will be of great value to our clients in the US and ROW."

Recently joining Chiltern is James Gunter as Director of Dedicated Biometrics Services. "I am pleased to announce James Gunter as an addition to our Chiltern Biometrics team," commented Alecia Barbee, Vice President, Global Biometrics, Chiltern. "James will head up the Biometrics FSPs globally, where his industry experience and client focus will lead this team in continued growth."

Dr. Cedric Burg has more than 17 years experience in the clinical research field and has a truly international profile having held global senior roles within both a CRO environment and Pharma. He holds a Master's degree in Life and Health Sciences from the Universite de Rennes I, France, and a doctorate in Molecular and Cellular Biology from the Universite de Nantes, France, and will be based out of Wilmington, NC, US.

James Gunter brings 16 years in life sciences experience, including 12 years in operational and management roles in the CRO industry. He has spent most of his career leading Biometrics and Information Technology teams globally in the Americas, Europe and Asia. In these roles, he has been responsible for building teams and implementing processes and technologies that improve the efficiency and quality of clinical trials. James is field-based in the US.

Company profileAbout Chiltern:Established in 1982, Chiltern is a leading global clinical CRO with extensive experience in the management of Phase I-IV clinical trials across a broad range of therapeutic areas, functional service provision and contract staffing solutions. Chiltern has conducted trials in more than 40 countries, employs nearly 1,400 people globally and offers services in Early Phase, Global Clinical Development, Late Phase, Biometrics, Medical and Regulatory Affairs and Resourcing Solutions. Chiltern prides itself as a development partner that offers flexibility, responsiveness and quality delivery. Further information is available at: www.chiltern.com. For More Information Contact:Natalie Chong

Susan OjanenMarketing Director

Marketing ExecutiveChiltern International Ltd.

Chiltern International Inc.171 Bath Road

1241 Volunteer ParkwaySlough

Suite 950Berkshire SL1 4AA

Bristol, TN 37620UNITED KINGDOM

USATel:  +44 (0) 1753 512 000

Tel:  +1 (423) 968 9533natalie.chong@chiltern.com 

susan.ojanen@chiltern.com


'/>"/>
SOURCE Chiltern
Copyright©2012 PR Newswire.
All rights reserved

Related biology news :

1. Chiltern Wins CRO Leadership Award From Life Science Leader
2. The CNIO welcomes the new academic year with a spotlight on cancer genetics
3. FirstMark Welcomes Renowned Cardiologist and Researcher Dr. Prediman K. Shah to Scientific Advisory Board
4. FirstMark Welcomes Renowned Cardiologist and Researcher Dr. Prediman K. Shah to Scientific Advisor Board
5. EMBO welcomes 55 leading life scientists as members
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/20/2017)... March 20, 2017 At this year,s CeBIT Chancellor ... biometrics manufacturer DERMALOG. The Chancellor came to the DERMALOG stand together with ... this year,s CeBIT partner country. At the largest German biometrics company the ... fingerprint, face and iris recognition as well as DERMALOGĀ“s multi-biometrics system.   ... ...
(Date:3/16/2017)... 16, 2017 CeBIT 2017 - Against identity fraud with DERMALOG solutions ... ... Used combined in one project, multi-biometric solutions provide a crucial contribution against ... Used combined in one project, ... ...
(Date:3/9/2017)... March 9, 2017 4Dx has publicly released ... Imaging Workshop at the University of Pennsylvania. Founder and ... deliver the latest data to world leaders in lung ... together leaders at the forefront of the industry to ... "The quality of the imaging is ...
Breaking Biology News(10 mins):
(Date:4/26/2017)... (PRWEB) , ... April 25, 2017 , ... LABS, Inc. ... were added to its extensive test menu: Nucleic Acid Testing (NAT) for ZIKV; ... LABS was only able to offer NAT screening for blood donors under an Investigational ...
(Date:4/26/2017)... ... April 26, 2017 , ... NextSteps ... and North America this May on the following dates: , ?    London, ... Taylor, Chairman of the Learning and Performance Institute will be the opening ...
(Date:4/26/2017)... April 26, 2017  Genisphere LLC, provider of ... signed a collaborative and sponsored research agreement with ... Muro . The overall goal of the partnership ... various 3DNA designs and formulations after in ... of the vasculature as well as inflammatory responses, ...
(Date:4/25/2017)... Oakland, California (PRWEB) , ... April 25, 2017 ... ... Artificial Intelligence (AI), leading supplier of Common Lisp (CL) development tools, and market ... 10.1 , which includes key performance enhancements now available within the most effective ...
Breaking Biology Technology: